| Barry Baker, SLP | |
|
201 Kimberly Ln, Williamstown, KY 41097-9458 | |
| (859) 824-7803 | |
| Not Available |
| Full Name | Barry Baker |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 201 Kimberly Ln, Williamstown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598364119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 11250 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barry Baker, SLP Po Box 54455, Cincinnati, OH 45254-0455 Ph: () - | Barry Baker, SLP 201 Kimberly Ln, Williamstown, KY 41097-9458 Ph: (859) 824-7803 |
News Archive
A federal appeals court Tuesday lambasted the Department of Veterans Affairs for failing to care for those suffering post-traumatic stress disorder and ordered a major overhaul of the behemoth agency. Treatment delays for PTSD and other combat-related mental illnesses are so "egregious" that they violate veterans' constitutional rights and contribute to the despair behind many of the 6,500 suicides among veterans each year, the U.S. 9th Circuit Court of Appeals said in its 2-1 ruling.
The new recommendations from the Society of Breast Imaging (SBI) and the American College of Radiology (ACR) on breast cancer screening, published in the January issue of the Journal of the American College of Radiology (JACR), state that breast cancer screening should begin at age 40 and earlier in high-risk patients. The recommendations also suggest appropriate utilization of medical imaging modalities such as mammography, magnetic resonance imaging (MRI), and ultrasound for breast cancer screening.
University of Pennsylvania School of Medicine researchers are recruiting healthy, HIV-negative adults to participate in a phase I clinical trial of an experimental HIV vaccine called PENNVAX-B, a DNA-based vaccine which is made using synthetic DNA-based HIV genes.
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy, the results of a phase III trial show.
› Verified 8 days ago
Tristan Brooke Mclean, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Kimberly Ln, Williamstown, KY 41097 Phone: 859-824-7803 |